jCyte, Inc
Total Awards:
2
Award Value:
$13,470,750
Institution type:
For profit
Short Name:
jCyte
Awards to the Institution
Program Type | Investigator | Grant Title | Award Value |
---|---|---|---|
Clinical Trial Stage Projects | Henry John Klassen | A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa | $5,175,000 |
Clinical Trial Stage Projects | Henry John Klassen | Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell) for Treatment of Retinitis Pigmentosa | $8,295,750 |
Total: $13,470,750.00 |